Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Abstract

Expansion of ATC in the presence of ipilimumab significantly improves not only the T cell proliferation but it also enhances cytokine secretion and the specific cytotoxicity of T cells armed with bispecific antibodies.